Si-Bone Inc (SIBN)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $1.06B
Last updated: Nov 17, 2026 at 4:21 PM ET
Si-Bone Inc (SIBN) Statistics
Si-Bone (SIBN) has a market cap of $1.06B and an enterprise value of $1.06B. Its share count is up 3.96% from a year earlier.
Total Valuation
Enterprise value is 0.03% above the market cap, as debt exceeds cash.
| Market Cap | $1.06B |
|---|---|
| Enterprise Value | $1.06B |
| Latest price (Nov 17, 2026) | $23.16 |
Key Dates
| Last Earnings Date | Nov 2, 2026 |
|---|---|
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 4.7x and 5.6x. Its year-end P/S ranged from 3.5x to 11.9x from 2018 to 2025.
| P/S Ratio | 4.7x |
|---|---|
| Forward P/S | 4.5x |
| P/B Ratio | 5.6x |
| P/OCF Ratio | 173.6x |
Price Statistics
The stock is up 32.95% over 52 weeks and trades 12.65% above its 50-day average.
| Beta (1Y) | 0.74 |
|---|---|
| 52-Week Change | +32.95% |
| 1-Month Change | +17.80% |
| 3-Month Change | +16.32% |
| 6-Month Change | +56.06% |
| 5-Year Change | -5.85% |
| Total Return (1Y) | +32.95% |
| Total Return (3Y CAGR) | +9.71% |
| Total Return (5Y CAGR) | +1.44% |
| Return vs SPY (1Y) | +14.58% |
| Max Drawdown (1Y) | -45.75% |
| Max Drawdown (3Y) | -46.20% |
| Sharpe Ratio (1Y) | 0.48 |
| Correlation with SPY (1Y) | 0.21 |
| 50-Day Average | $20.56 |
| 200-Day Average | $16.82 |
| 52-Week Range | $11.48 to $25.92 |
| RSI (14 Days) | 54.5 |
| Average Volume (20 Days) | 958.32K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 7.58x current liabilities, and total debt is 0.19x shareholder equity.
| Current Ratio | 7.58x |
|---|---|
| Quick Ratio | 6.15x |
| Debt / Equity | 0.19x |
| Interest Coverage | -6.89x |
Returns and Efficiency
Return on invested capital is -6.00% over the last 12 months, against a 5-year average of -8.28%.
| Return on Equity (ROE) | -7.41% |
|---|---|
| Return on Assets (ROA) | -5.33% |
| Return on Invested Capital (ROIC) | -6.00% |
| ROE (5Y Average) | -31.83% |
| ROA (5Y Average) | -21.74% |
| ROIC (5Y Average) | -8.28% |
| Asset Turnover | 0.90x |
| Inventory Turnover | 1.13x |
| Receivables Turnover | 7.04x |
| Cash Conversion Cycle | 300 days |
Scores
SIBN has an Altman Z-Score of 7.69, in the safe zone above 2.99, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 7.69 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 6 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $220.65M over the last 12 months is up 13.99% from the 12 months before.
| Revenue | $220.65M |
|---|---|
| Revenue Growth (YoY) | +13.99% |
| Gross Profit | $175.19M |
| Operating Income | -$16.71M |
| Pretax Income | -$13.71M |
| Net Income | -$13.69M |
| EBITDA | -$12.16M |
| Reported EPS (TTM) | -$0.31 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 71.92% of the $256.77M in total assets.
| Cash and Equivalents | $35.31M |
|---|---|
| Total Debt | $35.66M |
| Net Debt | $346.00K |
| Net Debt Per Share | $0.01 |
| Working Capital | $195.03M |
| Shareholder Equity | $184.68M |
| Book Value Per Share | $4.11 |
| Total Assets | $256.77M |
| Total Liabilities | $72.09M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $10.28M of capital spending, operating cash flow left -$4.19M of free cash flow.
| Operating Cash Flow | $6.08M |
|---|---|
| Capital Expenditures | $10.28M |
| Free Cash Flow | -$4.19M |
| FCF Per Share | -$0.09 |
| Depreciation and Amortization | $8.68M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -7.57%, against a 5-year average of -35.86%.
| Gross Margin | 79.40% |
|---|---|
| Operating Margin | -7.57% |
| Pretax Margin | -6.22% |
| Net Margin | -6.20% |
| EBITDA Margin | -5.51% |
| FCF Margin | -1.90% |
| Gross Margin (5Y Average) | 82.21% |
| Operating Margin (5Y Average) | -35.86% |
| Net Margin (5Y Average) | -35.88% |
Growth
Revenue grew 23.60% a year over 3 years.
| Revenue Growth (3Y CAGR) | +23.60% |
|---|---|
| Revenue Growth (5Y CAGR) | +22.32% |
| Book Value Per Share Growth (2Y CAGR) | -1.13% |
| Tangible Book Per Share Growth (2Y CAGR) | -1.13% |
Dividends and Yields
SIBN does not pay a dividend. Its free cash flow yield is -0.40%.
| FCF Yield | -0.40% |
|---|---|
| Buyback Yield | -0.06% |
| Shareholder Yield | -0.06% |
Peer Position
Against 12 similar companies, SIBN has the 5th highest P/S.
P/S RatioPeer median 2.7x
ROICPeer median -18.01%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +12.49%
| P/S Ratio | 4.7x vs 2.7x median |
|---|---|
| ROIC | -6.00% vs -18.01% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +13.99% vs +12.49% median |
Analyst Forecast
Consensus estimates put revenue growth at 15.52% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +15.52% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About SIBN
What is SIBN's market cap?
Si-Bone has a market cap of $1.06B. Its enterprise value, which adds debt and subtracts cash, is $1.06B.
How many shares of SIBN are outstanding?
Si-Bone has 44.90M shares outstanding. The count is up 3.96% from a year earlier.
Does SIBN pay a dividend?
No. Si-Bone does not pay a dividend.
How much debt does SIBN have?
Si-Bone has $35.66M of total debt and $35.31M of cash and equivalents, a net debt position of $346.00K.
SIBN pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors